title: Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases.
abstract: Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to myelin. Several reports have linked cyclosporine (CsA) with this alteration. The clinical features vary from qualitative alterations of consciousness to neurological deficits. Magnetic resonance imaging (MRI) of the brain demonstrates the damage to the white matter, which is essential for the differential diagnosis. We describe three clinical cases of leukoencephalopathy. The first case is a 43-year-old man received a cadaveric kidney transplant using immunosuppression with of mycophenolate mofetil, prednisone, and CsA. Four months later he developed meningism and bilateral sixth nerve palsy. The second case is a 50-year-old man with a cadaveric kidney transplant received immunosuppressive treatment with azathioprine and prednisone. As a result of gouty arthritis of the ankle, azathioprine was replaced with CsA to allow addition of allopurinol. Two weeks later he developed confusion and personality changes. The third case is a 16-year-old man received a orthotopic liver transplant. Postoperatively he suffered generalized tonic-clonic seizures. In all patients the CsA levels were toxic and signs of neurological alterations were present on MRI. All patients recovered rapidly after CsA withdrawal.
authors.affiliation: Department of Nephrology, Hospital del Salvador, Santiago, Chile. romunoz@msn.com
authors.forename: R
authors.initials: R
authors.lastname: Muñoz
authors.forename: M
authors.initials: M
authors.lastname: Espinoza
authors.forename: O
authors.initials: O
authors.lastname: Espinoza
authors.forename: A
authors.initials: A
authors.lastname: Andrade
authors.forename: E
authors.initials: E
authors.lastname: Bravo
authors.forename: F
authors.initials: F
authors.lastname: González
mesh_terms: D000293:Adolescent; D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D019693:Hepatitis, Autoimmune / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D004684:Leukoencephalitis, Acute Hemorrhagic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine